Drug Trial Radar · NCT04879628
Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis
Last checked: Nov 19, 2026Latest source record: Sep 28, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
129
Actual
Start
Jun 7, 2021
Primary completion
Sep 21, 2022
Study completion Aug 23, 2027
Sponsor
- Lead sponsor
- SanofiSanofi (SNY)
- Sponsor type
- Industry
- First posted
- May 10, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary Objective: To determine the efficacy of SAR441344 as measured by reduction of the number of new active brain lesions Secondary Objective: * To evaluate efficacy of SAR441344 on disease activity as assessed by other MRI measures * To evaluate the safety and tolerability of SAR441344 * To evaluate pharmacokinetics of SAR441344
Conditions
- Multiple Sclerosis
Interventions
SAR441344 IVDrug
Pharmaceutical form: Solution Route of administration: IV infusion
placebo IVDrug
Pharmaceutical form: Solution Route of administration: IV infusion
SAR441344 SCDrug
Pharmaceutical form: Solution Route of administration: SC injection
placebo SCDrug
Pharmaceutical form: Solution Route of administration: SC injection
MRI contrast-enhancing preparationsDrug
gadolinium compound, including but not limited to Magnevist, Multihance, Prohance, or Elucirem
Primary outcomes
What the sponsor says the trial is designed to measure.
- Mean Number of New Gadolinium (Gd)-Enhancing T1--Hyperintense (GdE T1) Lesions at Week 12 Relative to Week 8 as Measured by Brain Magnetic Resonance Imaging (MRI)Time frame: Week 8 and Week 12
Locations
37 sites in 10 countries. Site status is shown where the registry gives one.
Center for Neurology and Spine- Site Number : 8400007
Phoenix, Arizona
University of South Florida Site Number : 8400001
Tampa, Florida
The Neurological Institute Site Number : 8400004
Charlotte, North Carolina
Medical College of Wisconsin- Site Number : 8400006
Milwaukee, Wisconsin
Investigational Site Number : 1000002
Pleven, Bulgaria
Investigational Site Number : 1000003
Sofia, Bulgaria
Investigational Site Number : 1000001
Sofia, Bulgaria
Investigational Site Number : 1240001
Gatineau, Quebec, Canada
Investigational Site Number : 2030003
Brno, Czechia
Investigational Site Number : 2030002
Hradec Králové, Czechia
Investigational Site Number : 2030001
Jihlava, Czechia
Investigational Site Number : 2030005
Ostrava - Poruba, Czechia
Investigational Site Number : 2030004
Teplice, Czechia
Investigational Site Number : 2500006
Calais, France
Investigational Site Number : 2760012
Leipzig, Germany
Investigational Site Number : 2760004
Münster, Germany
Investigational Site Number : 6430002
Kazan', Russia
Investigational Site Number : 6430007
Moscow, Russia
Investigational Site Number : 6430006
Moscow, Russia
Investigational Site Number : 6430001
Moscow, Russia
Investigational Site Number : 6430003
Saint Petersburg, Russia
Investigational Site Number : 6430005
Saint Petersburg, Russia
Investigational Site Number : 6430004
Saint Petersburg, Russia
Investigational Site Number : 6430008
Tyumen, Russia
Investigational Site Number : 7240002
Vigo, Spain
Investigational Site Number : 7240004
Barcelona, Barcelona [Barcelona], Spain
Investigational Site Number : 7920004
Eskişehir, Turkey (Türkiye)
Investigational Site Number : 7920003
Istanbul, Turkey (Türkiye)
Investigational Site Number : 7920001
İzmit, Turkey (Türkiye)
Investigational Site Number : 7920002
Mersin, Turkey (Türkiye)
Investigational Site Number : 8040010
Dnipro, Ukraine
Investigational Site Number : 8040006
Dnipro, Ukraine
Investigational Site Number : 8040008
Ivano-Frankivsk, Ukraine
Investigational Site Number : 8040002
Kyiv, Ukraine
Investigational Site Number : 8040004
Lviv, Ukraine
Investigational Site Number : 8040003
Odesa, Ukraine
Investigational Site Number : 8040005
Vinnytsia, Ukraine
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.